Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Contingent Liabilities ₹31 Cr₹11 Cr₹0.16 Cr₹0.16 Cr₹2.52 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹31 Cr based on Mar2023 Consolidated results.
Year Contingent Liabilities
Mar2023₹31 Cr
Mar2022₹11 Cr
Mar2021₹0.16 Cr
Mar2020₹0.16 Cr
Mar2019₹2.52 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2023 ₹31 Cr
194.43
Mar2022 ₹11 Cr
6,423.93
Mar2021 ₹0.16 Cr
0.00
Mar2020 ₹0.16 Cr
-93.53
Mar2019 ₹2.52 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹439.9 Cr -1.7% 3.3% 70% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,920.0 Cr -2.3% -6.5% 55.3% Stock Analytics
CIPLA ₹113,794.0 Cr 4.1% -4.8% 55.6% Stock Analytics
DIVIS LABORATORIES ₹106,860.0 Cr 7.8% 17.4% 20.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,316.0 Cr 4% 0.8% 29.4% Stock Analytics
ZYDUS LIFESCIENCES ₹95,380.9 Cr -1.2% -5.2% 83.9% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-1.7%

3.3%

70%

SENSEX

0.9%

1.5%

23.6%


You may also like the below Video Courses